To evaluate the correlation between Best Corrected Visual Acuity (BCVA) and the following parameters in Stargardt Disease (STGD): Central Retinal Thickness (CR-T), Central Outer Nuclear Layer Thickness (C-ONL-T), Areas of macular Photoreceptor loss (PHRa), and Retinal Pigment Epithelium (RPE) loss (RPEa).
Methods:
A total of 64 eyes of 32 STGD patients were included in the study. All patients received a comprehensive ophthalmological examination, color fundus photographs, fundus auto-fluorescence imaging, and Optical Coherence Tomography (OCT). The CR-T and C-ONL-T were evaluated from standard SD-OCT scans. The PHRa and RPEa were calculated from enface OCT scans (sub RPE slab and photoreceptor slab). The collected OCT parameters were evaluated for possible association with BCVA.
Results:
The mean macular PHRa and RPEa was 16.16 ± 13.36 and 12.05 ± 12.57 mm2 respectively. The mean CR-T measured 120.78 ± 41.49 μm while the mean C-ONL-T was assessed at 4.60 ± 13.73 μm. BCVA showed the highest correlation with the C-ONL-T (r = −0.72; p < 0.001) while there was no correlation with the CR-T (r = −0.17; p = 1.00).
Conclusions:
Enface OCT permits a rapid and precise quantitative evaluation of the macular PHR and RPE atrophy area in STGD. Nonetheless, the OCT parameter that showed the highest correlation with visual acuity in STGD was the ONL thickness.
StargardtK.Über familiäre, progressive degeneration in der Maculagegend des Auges. Albr von Græfes Arch für Ophthalmol1909; 71(3): 534–550.
2.
SunHNathansJ.Mechanistic studies of ABCR, the ABC transporter in photoreceptor outer segments responsible for autosomal recessive Stargardt disease. J Bioenerg Biomembr2001; 33(6): 523–530.
3.
FishmanGAFarberMPatelBS, et al. Visual acuity loss in patents with Stargardt’s macular dystrophy. Ophthalmology. 1987; 94(7): 809–814.
4.
CideciyanAVAlemanTSSwiderM, et al. Mutations in ABCA4 result in accumulation of lipofuscin before slowing of the retinoid cycle: A reappraisal of the human disease sequence. Hum Mol Genet2004; 13(5): 525–534.
5.
RaduRAYuanQHuJ, et al. Accelerated accumulation of lipofuscin pigments in the RPE of a mouse model for ABCA4-mediated retinal dystrophies following vitamin A supplementation. Investig Ophthalmol Vis Sci2008; 49(9): 3821–3829.
6.
ErgunEHermannBWirtitschM, et al. Assessment of central visual function in Stargardt’s disease/fundus flavimaculatus with ultrahigh-resolution optical coherence tomography. Investig Ophthalmol Vis Sci2005; 46(1): 310–316.
7.
TestaFRossiSSodiA, et al. Correlation between photoreceptor layer integrity and visual function in patients with stargardt disease: Implications for gene therapy. Investig Ophthalmol Vis Sci2012; 53(8): 4409.
8.
SodiAMuccioloDPCipolliniF, et al. En face OCT in Stargardt disease. Graefes Arch Clin Exp Ophthalmol2016; 254(9): 1669–1679.
9.
MelilloPTestaFRossiS, et al. En face spectral-domain optical coherence tomography for the monitoring of lesion area progression in stargardt disease. Investig Ophthalmol Vis Sci2016; 57(9): OCT247–OCT252.
10.
AlabduljalilTPatelRCAlqahtaniAA, et al. Correlation of outer retinal degeneration and choriocapillaris loss in stargardt disease using en face optical coherence tomography and optical coherence tomography angiography. Am J Ophthalmol2019; 202: 79–90.
11.
FujinamiKZernantJChanaRK, et al. Clinical and molecular characteristics of childhood-onset stargardt disease. Ophthalmology2015; 122(2): 326–334.
12.
StaurenghiGSaddaSChakravarthyU, et al. Proposed lexicon for anatomic landmarks in normal posterior segment spectral-domain optical coherence tomography: The IN•OCT consensus. Ophthalmology2014; 121(8): 1572–1578.
13.
LujanBJRoordaACroskreyJA, et al. Directional optical coherence tomography provides accurate outer nuclear layer and Henle fiber layer measurements. Retina2015; 35(8): 1511–1520.
14.
SpaideRFCurcioCA.Anatomical correlates to the bands seen in the outer retina by optical coherence tomography: literature review and model. Retina2011; 31(8): 1609–1619.
15.
ZhangZQZhangCFDongFT, et al. Relationship between central visual acuity and retinal volume of macular fovea accessed by spectral domain optical coherence tomography in Stargardt disease. Chinese J Ophthalmol2011; 47(7): 628–632.
16.
Battaglia ParodiMLa SpinaCTrioloG, et al. Correlation of SD-OCT findings and visual function in patients with retinitis pigmentosa. Graefes Arch Clin Exp Ophthalmol2016; 254(7): 1275–1279.
17.
MenghiniMLujanBJZayit-SoudryS, et al. Correlation of outer nuclear layer thickness with cone density values in patients with retinitis pigmentosa and healthy subjects. Investig Ophthalmol Vis Sci2015; 56(1): 372–381.
18.
DooleyITreacyMOrourkeM, et al. Serial spectral domain ocular coherence tomography measurement of outer nuclear layer thickness in rhegmatogenous retinal detachment repair. Curr Eye Res2015; 40(10): 1073–1076.
19.
WuLNagasakiTSparrowJR.Photoreceptor cell degeneration in Abcr-/- mice. Adv Exp Med Biol2010; 24(1): 158–164.
20.
HuangWCCideciyanAVRomanAJ, et al. Inner and outer retinal changes in retinal degenerations associated with ABCA4 mutations. Investig Ophthalmol Vis Sci2014; 55(3): 1810–1822.
21.
KongXHoAMunozB, et al. Reproducibility of measurements of retinal structural parameters using optical coherence tomography in stargardt disease. Transl Vis Sci Technol2019; 8(3): 46.
22.
ChuiTYPSongHClarkCA, et al. Cone photoreceptor packing density and the outer nuclear layer thickness in healthy subjects. Investig Ophthalmol Vis Sci2012; 53(7): 3545–3553.
23.
GelmanRSmithRTTsangSH.Diagnostic accuracy evaluation of visual acuity and fundus autofluorescence macular geographic atrophy area for the discrimination of stargardt groups. Retina2016; 36(8): 1596.
24.
ArepalliSTraboulsiEIEhlersJP.Ellipsoid zone mapping and outer retinal assessment in stargardt disease. Retina2018; 38(7): 1427–1431.
25.
CaiCXLightJGHandaJT.Quantifying the rate of ellipsoid zone loss in Stargardt disease. Am J Ophthalmol2018; 186: 1–9.
26.
TannaPGeorgiouMStraussRW, et al. Cross-sectional and longitudinal assessment of the ellipsoid zone in childhood-onset stargardt disease. Transl Vis Sci Technol2019; 8(2): 1
27.
LambertusSLindnerMBaxNM, et al. Progression of late-onset stargardt disease. Investig Ophthalmol Vis Sci2016; 57(13): 5186–5191.
28.
LightJGFardMAYaseriM, et al. Stargardt disease beyond flecks and atrophy. Retina2017; 37(12): 2352–2361.
29.
GomesNLGreensteinVCCarlsonJN, et al. A comparison of fundus autofluorescence and retinal structure in patients with stargardt disease. Investig Ophthalmol Vis Sci2009; 50(8): 3953–3959.
30.
SongHRossiEALatchneyL, et al. Cone and rod loss in stargardt disease revealed by adaptive optics scanning light ophthalmoscopy. JAMA Ophthalmol2015; 133(10): 1198–1203.
31.
BernsteinASunnessJSApplegateCA, et al. Mapping the dense scotoma and its enlargement in stargardt disease. Retina2016; 36(9): 1741–1750.
32.
SiskRALengT.Multimodal imaging and multifocal electroretinography demonstrate autosomal recessive stargardt disease may present like occult macular dystrophy. Retina2014; 34(8): 1567–1575.
33.
KhanKNKasilianMMahrooOAR, et al. Early patterns of macular degeneration in ABCA4-associated retinopathy. Ophthalmology2018; 125(5): 735–746.
34.
LeeWNõupuuKOllM, et al. The external limiting membrane in early–onset stargardt disease. Investig Ophthalmol Vis Sci2014; 55(10): 6139–6149.
35.
BurkeTRYzerSZernantJ, et al. Abnormality in the external limiting membrane in early Stargardt disease. Ophthalmic Genet2013; 34(1–2): 75–77.
36.
BaxNMLambertusSCremersFPM, et al. The absence of fundus abnormalities in Stargardt disease. Graefes Arch Clin Exp Ophthalmol2019; 257(6): 1147–1157.
